Pain Intensity and Time to Death of Cancer Patients Referred to Palliative Care

Detalhes bibliográficos
Autor(a) principal: Barata, Pedro
Data de Publicação: 2016
Outros Autores: Santos, Filipa, Mesquita, Graça, Cardoso, Alice, Custódio, Maria Paula, Alves, Marta, Papoila, Ana Luísa, Barbosa, António, Lawlor, Peter
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7557
Resumo: Introduction: Pain is a common symptom experienced by cancer patients, especially in those with advanced disease. Our aim was to describe pain intensity in advanced cancer patients, referred to the palliative care unit, the factors underlying moderate to severe pain and its prognostic values.Material and Methods: This was a prospective observational study. All patients with mestastatic solid tumors and with no specific oncologic treatment were included. Pain intensity was accessed using the pain scale from Edmonton Symptom Assessment Scale, rated from 0 to 10 on a numerical scale, where zero = no pain and 10 = worst possible pain.Results: Between October 2012 and June 2015, a total of 301 patients participated in the study. The median age was 69 years, (37 - 94); most of the patients were men (57%) and 64.8% had a performance status of 3/4. About 42% reported pain severity ≥ 4 and 74% were medicated with opioids. Multivariate analysis indicated a correlation between performance status and reported pain (OR: 1.7; IC 95%: 1.0 - 2.7; p = 0.045). Median overall survival was 37 days (IC 95%: 28 - 46). Patients reporting moderate to severe pain (pain severity ≥ 4) had a median survival of 29 days (IC 95%: 21 - 37), comparing with those who had no or moderate pain with median survival of 49 days (IC 95%: 35 - 63) (p = 0.022).Discussion: The performance status was associated with more intense pain. The performance status, hospitalization, intra-abdominal metastization and opioid analgesia were associated with shorter time to death in advanced cancer patients referred to palliative care.Conclusion: Cancer pain continues to be a major clinical problem in advanced cancer patients.
id RCAP_5482dc409467ce8a49df61e1fa58751c
oai_identifier_str oai:ojs.www.actamedicaportuguesa.com:article/7557
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str
spelling Pain Intensity and Time to Death of Cancer Patients Referred to Palliative CareAssociação da Intensidade de Dor no Tempo Até à Morte dos Doentes Oncológicos Referenciados aos Cuidados PaliativosNeoplasmsPain MeasurementPalliative Care.Cuidados PaliativosMedição da DorNeoplasias.Introduction: Pain is a common symptom experienced by cancer patients, especially in those with advanced disease. Our aim was to describe pain intensity in advanced cancer patients, referred to the palliative care unit, the factors underlying moderate to severe pain and its prognostic values.Material and Methods: This was a prospective observational study. All patients with mestastatic solid tumors and with no specific oncologic treatment were included. Pain intensity was accessed using the pain scale from Edmonton Symptom Assessment Scale, rated from 0 to 10 on a numerical scale, where zero = no pain and 10 = worst possible pain.Results: Between October 2012 and June 2015, a total of 301 patients participated in the study. The median age was 69 years, (37 - 94); most of the patients were men (57%) and 64.8% had a performance status of 3/4. About 42% reported pain severity ≥ 4 and 74% were medicated with opioids. Multivariate analysis indicated a correlation between performance status and reported pain (OR: 1.7; IC 95%: 1.0 - 2.7; p = 0.045). Median overall survival was 37 days (IC 95%: 28 - 46). Patients reporting moderate to severe pain (pain severity ≥ 4) had a median survival of 29 days (IC 95%: 21 - 37), comparing with those who had no or moderate pain with median survival of 49 days (IC 95%: 35 - 63) (p = 0.022).Discussion: The performance status was associated with more intense pain. The performance status, hospitalization, intra-abdominal metastization and opioid analgesia were associated with shorter time to death in advanced cancer patients referred to palliative care.Conclusion: Cancer pain continues to be a major clinical problem in advanced cancer patients.Introdução: A dor é uma experiência frequente nos doentes com cancro, especialmente naqueles em fase final de vida. Com este estudo, pretendemos estudar a intensidade de dor nos doentes com cancro avançado, referenciados aos cuidados paliativos, analisar os factores associados à ocorrência de dor moderada ou intensa e avaliar a sua relação com o tempo até à morte destes doentes.Material e Métodos: Estudo prospectivo observacional que incluiu consecutivamente todos os doentes referenciados aos cuidados paliativos com tumores sólidos metastizados e sem tratamento oncológico específico. Foi considerada a intensidade de dor da escala de Edmonton, de acordo com a graduação zero a 10, onde 0 = ausência de dor e 10 = máxima dor possível.Resultados: Entre outubro de 2012 e junho de 2015, foram incluídos 301 doentes, com idade mediana de 69 anos (37 - 94), 57% homens e 64,8% dos doentes com performance status 3/4. Aproximadamente 42% dos doentes apresentaram dor ≥ 4 e cerca de 74,4% estavam medicados com analgesia opióide. A intensidade de dor esteve associada ao performance status dos doentes, de acordo com a análise multivariável (OR: 1,7; IC 95%: 1,0 - 2,7; p = 0,045). A mediana do tempo de sobrevivência foi de 37 dias (IC 95%: 28 - 46), tendo os doentes com dor moderada ou intensa (intensidade de dor ≥ 4) uma mediana de sobrevivência de 29 dias (IC 95%: 21 - 37), comparada com os 49 dias (IC 95%: 35 - 63) para os doentes sem dor ou dor ligeira (p = 0,022).Discussão: O performance status, para além de ter estado associado a uma maior intensidade de dor, esteve associado a um menor tempo até à morte dos doentes com cancro avançado referenciados aos cuidados paliativos. Também o internamento, a presença de metastização intra-abdominal e a analgesia opióide estiveram associados de forma negativa ao tempo até à morte destes doentes.Conclusão: A dor oncológica continua a ser um problema clinicamente relevante nos doentes com cancro avançado.Ordem dos Médicos2016-11-30info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfapplication/pdfapplication/mswordapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7557oai:ojs.www.actamedicaportuguesa.com:article/7557Acta Médica Portuguesa; Vol. 29 No. 11 (2016): November; 694-701Acta Médica Portuguesa; Vol. 29 N.º 11 (2016): Novembro; 694-7011646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7557https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7557/4818https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7557/8338https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7557/8568https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7557/8607Direitos de Autor (c) 2016 Acta Médica Portuguesainfo:eu-repo/semantics/openAccessBarata, PedroSantos, FilipaMesquita, GraçaCardoso, AliceCustódio, Maria PaulaAlves, MartaPapoila, Ana LuísaBarbosa, AntónioLawlor, Peter2022-12-20T11:05:15ZPortal AgregadorONG
dc.title.none.fl_str_mv Pain Intensity and Time to Death of Cancer Patients Referred to Palliative Care
Associação da Intensidade de Dor no Tempo Até à Morte dos Doentes Oncológicos Referenciados aos Cuidados Paliativos
title Pain Intensity and Time to Death of Cancer Patients Referred to Palliative Care
spellingShingle Pain Intensity and Time to Death of Cancer Patients Referred to Palliative Care
Barata, Pedro
Neoplasms
Pain Measurement
Palliative Care.
Cuidados Paliativos
Medição da Dor
Neoplasias.
title_short Pain Intensity and Time to Death of Cancer Patients Referred to Palliative Care
title_full Pain Intensity and Time to Death of Cancer Patients Referred to Palliative Care
title_fullStr Pain Intensity and Time to Death of Cancer Patients Referred to Palliative Care
title_full_unstemmed Pain Intensity and Time to Death of Cancer Patients Referred to Palliative Care
title_sort Pain Intensity and Time to Death of Cancer Patients Referred to Palliative Care
author Barata, Pedro
author_facet Barata, Pedro
Santos, Filipa
Mesquita, Graça
Cardoso, Alice
Custódio, Maria Paula
Alves, Marta
Papoila, Ana Luísa
Barbosa, António
Lawlor, Peter
author_role author
author2 Santos, Filipa
Mesquita, Graça
Cardoso, Alice
Custódio, Maria Paula
Alves, Marta
Papoila, Ana Luísa
Barbosa, António
Lawlor, Peter
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Barata, Pedro
Santos, Filipa
Mesquita, Graça
Cardoso, Alice
Custódio, Maria Paula
Alves, Marta
Papoila, Ana Luísa
Barbosa, António
Lawlor, Peter
dc.subject.por.fl_str_mv Neoplasms
Pain Measurement
Palliative Care.
Cuidados Paliativos
Medição da Dor
Neoplasias.
topic Neoplasms
Pain Measurement
Palliative Care.
Cuidados Paliativos
Medição da Dor
Neoplasias.
description Introduction: Pain is a common symptom experienced by cancer patients, especially in those with advanced disease. Our aim was to describe pain intensity in advanced cancer patients, referred to the palliative care unit, the factors underlying moderate to severe pain and its prognostic values.Material and Methods: This was a prospective observational study. All patients with mestastatic solid tumors and with no specific oncologic treatment were included. Pain intensity was accessed using the pain scale from Edmonton Symptom Assessment Scale, rated from 0 to 10 on a numerical scale, where zero = no pain and 10 = worst possible pain.Results: Between October 2012 and June 2015, a total of 301 patients participated in the study. The median age was 69 years, (37 - 94); most of the patients were men (57%) and 64.8% had a performance status of 3/4. About 42% reported pain severity ≥ 4 and 74% were medicated with opioids. Multivariate analysis indicated a correlation between performance status and reported pain (OR: 1.7; IC 95%: 1.0 - 2.7; p = 0.045). Median overall survival was 37 days (IC 95%: 28 - 46). Patients reporting moderate to severe pain (pain severity ≥ 4) had a median survival of 29 days (IC 95%: 21 - 37), comparing with those who had no or moderate pain with median survival of 49 days (IC 95%: 35 - 63) (p = 0.022).Discussion: The performance status was associated with more intense pain. The performance status, hospitalization, intra-abdominal metastization and opioid analgesia were associated with shorter time to death in advanced cancer patients referred to palliative care.Conclusion: Cancer pain continues to be a major clinical problem in advanced cancer patients.
publishDate 2016
dc.date.none.fl_str_mv 2016-11-30
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7557
oai:ojs.www.actamedicaportuguesa.com:article/7557
url https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7557
identifier_str_mv oai:ojs.www.actamedicaportuguesa.com:article/7557
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7557
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7557/4818
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7557/8338
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7557/8568
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7557/8607
dc.rights.driver.fl_str_mv Direitos de Autor (c) 2016 Acta Médica Portuguesa
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Direitos de Autor (c) 2016 Acta Médica Portuguesa
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
application/msword
application/pdf
dc.publisher.none.fl_str_mv Ordem dos Médicos
publisher.none.fl_str_mv Ordem dos Médicos
dc.source.none.fl_str_mv Acta Médica Portuguesa; Vol. 29 No. 11 (2016): November; 694-701
Acta Médica Portuguesa; Vol. 29 N.º 11 (2016): Novembro; 694-701
1646-0758
0870-399X
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1777301649099849728